Check each claim against its experiments, reported results, scope, and stated limitations.Know what the science actually supports before you trust the answer.
Press Enter β΅ to start review
Explore by Goal
"The universe is not only queerer than we suppose, but queerer than we can suppose."
- J.B.S. Haldane
Quick Explanation
Copied
iNKT and MAIT Cell Alterations in Diabetes (Magalhaes, Kiaf & Lehuen, Frontiers in Immunology, 2015) is a well-cited narrative review that integrates iNKT cell defects in T1D/T2D with emerging MAIT cell data in obesity, and hypothesizes a microbiotaβimmune axis
Long Explanation
Evidence Base and Core Claims
This 2015 review (Magalhaes, Kiaf & Lehuen, Institut Cochin) synthesizes iNKT and MAIT cell alterations across T1D, T2D and obesity, drawing heavily on the authors' own primary work including their J Clin Invest study showing MAIT cell frequency reductions, increased IL-17 production, and adipose tissue retention in obese/T2D patients . For iNKT cells, the review correctly highlights NOD mouse protective mechanisms via IL-4/IL-10 and Treg induction, while transparently acknowledging that human T1D data are contradictory .
Schematic derived from qualitative claims in the review text; exact numeric values for obese adult vs lean MAIT frequencies are not reported in the review itself β this is an interpretive illustration, not measured data.
Strengths
Timely integration of two unconventional T cell lineages with metabolism
Honest acknowledgment of contradictory human iNKT data
Forward-looking microbiota hypothesis now partly supported by later work showing archaeal riboflavin drives MAIT responses
No declared conflicts of interest; public funding (INSERM, CNRS, ANR, FRM)
Limitations and Blind Spots
Species over-generalization: NOD mouse iNKT biology does not reliably translate to human T1D; the review acknowledges this but does not quantify the discordance
Causality not established: Whether MAIT depletion drives insulin resistance or reflects it remains unresolved β the authors' own bariatric surgery data show partial restoration but persistent Th17 skewing at 12 months
Cohort heterogeneity: Obese children showed increased MAIT frequency with hyperinsulinemia, opposite to adults β a key confounder inadequately explored
No mechanistic depth on microbiotaβMAIT axis: The hypothesis is plausible but the review offers no direct experimental evidence linking specific microbial metabolites to MAIT cell alteration in metabolic disease
Publication bias risk: The review does not discuss negative studies or failed replication attempts in the iNKTβT1D literature systematically
How Future Work Changed the Picture
Subsequent studies confirmed MAIT alterations in metabolic contexts but revealed complexity: obese children show increased MAIT frequency , and microbiota-MAIT links involve archaeal rather than primarily bacterial sources, which the original review did not anticipate .
Confidence and Falsifiability
Confidence in the review's synthesis: Moderate. The MAITβobesity association is well-supported by primary data; the iNKTβT1D protective mechanism in mice is robust but human relevance remains uncertain. The microbiota hypothesis is testable: it would be falsified if microbiota manipulation in T1D/T2D models fails to alter iNKT/MAIT frequency or if microbiota changes are shown to be consequences rather than causes of metabolic inflammation.
Feedback:
Updated: October 08, 2026
BGPT Paper Review
Study Novelty
70%
First review to co-synthesize iNKT and MAIT cell defects across both T1D and T2D with a microbiota-immunometabolism framework, published at a time when MAIT cell data in metabolic disease were nascent.
Scientific Quality
60%
Well-structured narrative review with transparent discussion of contradictory data and appropriate caveats; however, it is not a systematic review, cites primarily the authors' own work for MAIT claims, and offers no quantitative meta-analysis or pre-registered search strategy.
Study Generality
70%
Bridges immunology, metabolism, and microbiome science with implications beyond diabetes (obesity, inflammation, mucosal immunity), though the core focus remains disease-specific.
Study Usefulness
70%
Valuable conceptual roadmap that stimulated subsequent research into MAIT-metabolism links and microbiota modulation; practical utility limited by lack of therapeutic recommendations.
Study Reproducibility
40%
As a narrative review with no search methodology, no quantitative synthesis, and no data deposition, reproducibility is inherently low; primary underlying studies are separately assessable.
We'll email you the results when your analysis is finished.
Hypothesis Graveyard
iNKT cell numerical deficiency is a universal hallmark of human T1D: falsified by multiple studies showing no difference or even increased frequencies, and by the recognition that subset composition (iNKT17 enrichment) matters more than total cell number.
Gut bacterial riboflavin is the primary driver of circulating MAIT cell abundance: challenged by 2026 metagenomic evidence that archaeal riboflavin pathway abundance, not bacterial, correlates with MAIT frequency and activation.